M. Matériel, Design de l'étude et recrutement des patients, p.25

J. He, P. Whelton, B. Vu, and M. Klag, Aspirin and Risk of Hemorrhagic Stroke, JAMA, vol.280, issue.22, pp.1930-1935, 1998.
DOI : 10.1001/jama.280.22.1930

A. Naidech, B. Jovanovic, S. Liebling, R. Garg, S. Bassin et al., Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage, Stroke, vol.40, issue.7, pp.2398-401, 2009.
DOI : 10.1161/STROKEAHA.109.550939

K. Toyoda, Y. Okada, K. Minematsu, M. Kamouchi, S. Fujimoto et al., Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage, Neurology, vol.65, issue.7, pp.1000-1004, 2005.
DOI : 10.1212/01.wnl.0000179178.37713.69

S. Davis, J. Broderick, M. Hennerici, N. Brun, M. Diringer et al., Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage, Neurology, vol.66, issue.8, pp.1175-81, 2006.
DOI : 10.1212/01.wnl.0000208408.98482.99

Y. Fujii, S. Takeuchi, O. Sasaki, T. Minakawa, and R. Tanaka, Multivariate Analysis of Predictors of Hematoma Enlargement in Spontaneous Intracerebral Hemorrhage. Stroke, pp.1160-1166, 1998.

R. Leira, A. Dávalos, Y. Silva, A. Gil-peralta, J. Tejada et al., Early neurologic deterioration in intracerebral hemorrhage: Predictors and associated factors, Neurology, vol.63, issue.3, pp.461-468, 2004.
DOI : 10.1212/01.WNL.0000133204.81153.AC

T. Brott, J. Broderick, R. Kothari, W. Barsan, T. Tomsick et al., Early Hemorrhage Growth in Patients With Intracerebral Hemorrhage, Stroke, vol.28, issue.1, pp.1-5, 1997.
DOI : 10.1161/01.STR.28.1.1

L. Sansing, S. Messe, B. Cucchiara, S. Cohen, P. Lyden et al., Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH, Neurology, vol.72, issue.16, pp.1397-402, 2009.
DOI : 10.1212/01.wnl.0000342709.31341.88

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677505

P. Campbell, S. Yadla, A. Sen, J. Jallo, and P. Jabbour, Emergency reversal of clopidogrel in the setting of spontaneous intracerebral hemorrhage. World Neurosurg, pp.100-104, 2011.

K. Lacut, L. Gal, G. Seizeur, R. Prat, G. Mottier et al., Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality, Fundamental & Clinical Pharmacology, vol.14, issue.3, pp.327-360, 2007.
DOI : 10.1213/01.ANE.0000100682.84799.E8

URL : https://hal.archives-ouvertes.fr/hal-00688284

J. Broderick, M. Diringer, M. Hill, N. Brun, S. Mayer et al., Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis, Stroke, vol.38, issue.3, pp.1072-1077, 2007.
DOI : 10.1161/01.STR.0000258078.35316.30

W. Mcmillian and F. Rogers, Management of Prehospital Antiplatelet and Anticoagulant Therapy in Traumatic Head Injury: A Review, The Journal of Trauma: Injury, Infection, and Critical Care, vol.66, issue.3, pp.942-50, 2009.
DOI : 10.1097/TA.0b013e3181978e7b

A. Mina, J. Knipfer, D. Park, H. Bair, G. Howells et al., Intracranial Complications of Preinjury Anticoagulation in Trauma Patients with Head Injury, The Journal of Trauma: Injury, Infection, and Critical Care, vol.53, issue.4, pp.668-72, 2002.
DOI : 10.1097/00005373-200210000-00008

F. Ivascu, G. Howells, F. Junn, H. Bair, P. Bendick et al., Predictors of Mortality in Trauma Patients With Intracranial Hemorrhage on Preinjury Aspirin or Clopidogrel, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.4, pp.785-793, 2008.
DOI : 10.1097/TA.0b013e3181848caa

J. Roquer, R. Campello, A. Gomis, M. Ois, A. Puente et al., Previous antiplatelet therapy is an independent predictor of 30?day mortality after spontaneous supratentorial intracerebral hemorrhage, Journal of Neurology, vol.54, issue.4, pp.412-418, 2005.
DOI : 10.1007/s00415-005-0659-5

B. Thompson, Y. Béjot, V. Caso, J. Castillo, H. Christensen et al., Prior antiplatelet therapy and outcome following intracerebral hemorrhage: A systematic review, Neurology, vol.75, issue.15, pp.1333-1375, 2010.
DOI : 10.1212/WNL.0b013e3181f735e5

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013483

C. Creutzfeldt, J. Weinstein, W. Longstreth, K. Becker, T. Mcpharlin et al., Prior Antiplatelet Therapy, Platelet Infusion Therapy, and Outcome after Intracerebral Hemorrhage, Journal of Stroke and Cerebrovascular Diseases, vol.18, issue.3, pp.221-229, 2009.
DOI : 10.1016/j.jstrokecerebrovasdis.2008.10.007

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830090

P. Saloheimo, M. Ahonen, S. Juvela, J. Pyhtinen, E. Savolainen et al., Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death, Stroke, vol.37, issue.1, pp.129-162, 2006.
DOI : 10.1161/01.STR.0000196991.03618.31

C. Ohm, A. Mina, G. Howells, H. Bair, and P. Bendick, Effects of Antiplatelet Agents on Outcomes for Elderly Patients With Traumatic Intracranial Hemorrhage, The Journal of Trauma: Injury, Infection, and Critical Care, vol.58, issue.3, pp.518-540, 2005.
DOI : 10.1097/01.TA.0000151671.35280.8B

C. Foerch, M. Sitzer, H. Steinmetz, and T. Neumann-haefelin, Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral Hemorrhage, Stroke, vol.37, issue.8, pp.2165-2172, 2006.
DOI : 10.1161/01.STR.0000231842.32153.74

M. Moussouttas, R. Malhotra, L. Fernandez, M. Maltenfort, M. Holowecki et al., Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocrit Care, Feb, vol.12, issue.1, pp.24-33, 2010.

G. Fortuna, E. Mueller, L. James, L. Shutter, and K. Butler, The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury, Surgery, vol.144, issue.4, pp.598-603, 2008.
DOI : 10.1016/j.surg.2008.06.009

D. Wong, F. Lurie, and L. Wong, The Effects of Clopidogrel on Elderly Traumatic Brain Injured Patients, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.6, pp.1303-1311, 2008.
DOI : 10.1097/TA.0b013e318185e234

K. Jones, C. Sharp, A. Mangram, and E. Dunn, The effects of preinjury clopidogrel use on older trauma patients with head injuries, The American Journal of Surgery, vol.192, issue.6, pp.743-748, 2006.
DOI : 10.1016/j.amjsurg.2006.08.037

A. Holbrook, S. Schulman, D. Witt, P. Vandvik, J. Fish et al., Evidence-Based Management of Anticoagulant Therapy, Chest, vol.141, issue.2, pp.152-84, 2012.
DOI : 10.1378/chest.11-2295

J. Batchelor and A. Grayson, A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage, BMJ Open, vol.2, issue.2, p.588, 2012.
DOI : 10.1136/bmjopen-2011-000588

M. Martin and L. Conlon, Does platelet transfusion improve outcomes in patients with spontaneous or traumatic intracerebral hemorrhage? Ann Emerg Med, pp.58-61, 2013.
DOI : 10.1016/j.annemergmed.2012.03.025

M. Baharoglu, C. Cordonnier, A. Salman, R. De-gans, K. Koopman et al., Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial, The Lancet, vol.387, issue.10038, pp.2605-2618, 2016.
DOI : 10.1016/S0140-6736(16)30392-0

J. Hemphill, S. Greenberg, C. Anderson, K. Becker, B. Bendok et al., Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, Stroke, 2015.

J. Rankin, Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis, Scottish Medical Journal, vol.2, issue.5, pp.200-215, 1957.
DOI : 10.1177/003693305700200504

R. Bonita and R. Beaglehole, Recovery of motor function after stroke, Stroke, vol.19, issue.12, pp.1497-500, 1988.
DOI : 10.1161/01.STR.19.12.1497

B. Jennett and M. Bond, Assessment of outcome after severe brain damage, Lancet Lond Engl, vol.1, issue.7905, pp.480-484, 1975.

J. Semple, J. Italiano, and J. Freedman, Platelets and the immune continuum, Nature Reviews Immunology, vol.25, issue.4, pp.264-74
DOI : 10.1038/nri2956

M. Wadhwa, J. Seghatchian, and R. Thorpe, Are cytokines in platelet concentrates responsible for febrile transfusion reactions? Transfus Sci, pp.367-71, 1997.

N. Blumberg, K. Gettings, C. Turner, J. Heal, and R. Phipps, An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions, Transfusion, vol.160, issue.10, 2006.
DOI : 10.1182/blood-2003-07-2203

S. Khan, M. Kelher, J. Heal, N. Blumberg, L. Boshkov et al., Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury, Blood, vol.108, issue.7, pp.2455-62, 2006.
DOI : 10.1182/blood-2006-04-017251

W. Savage, J. Savage, A. Tobian, C. Thoburn, R. Hamilton et al., Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion (Paris), pp.575-81, 2012.
DOI : 10.1111/j.1537-2995.2011.03310.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711211

F. Cognasse, J. Payrat, L. Corash, J. Osselaer, and O. Garraud, Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand, Blood, vol.112, issue.12, pp.4779-4780, 2008.
DOI : 10.1182/blood-2008-05-157578

R. Kothari, T. Brott, J. Broderick, W. Barsan, L. Sauerbeck et al., The ABCs of Measuring Intracerebral Hemorrhage Volumes, Stroke, vol.27, issue.8, pp.1304-1309, 1996.
DOI : 10.1161/01.STR.27.8.1304

J. Gebel, C. Sila, M. Sloan, C. Granger, J. Weisenberger et al., Comparison of the ABC/2 Estimation Technique to Computer-Assisted Volumetric Analysis of Intraparenchymal and Subdural Hematomas Complicating the GUSTO-1 Trial, Stroke, vol.29, issue.9, pp.1799-801, 1998.
DOI : 10.1161/01.STR.29.9.1799

K. Sheth, T. Cushing, L. Wendell, M. Lev, J. Romero et al., Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care, Feb, vol.12, issue.1, pp.30-34, 2010.

W. Freeman, K. Barrett, J. Bestic, J. Meschia, D. Broderick et al., Computer-Assisted Volumetric Analysis Compared With ABC/2 Method for Assessing Warfarin-Related Intracranial Hemorrhage Volumes, Neurocritical Care, vol.73, issue.3, pp.307-319, 2008.
DOI : 10.1007/s12028-008-9089-4

M. Khan, G. Baird, R. Elias, J. Rodriguez-srednicki, S. Yaghi et al., Comparison of Intracerebral Hemorrhage Volume Calculation Methods and Their Impact on Scoring Tools, Journal of Neuroimaging, vol.84, issue.1, 2016.
DOI : 10.1111/jon.12370

A. Ducruet, Z. Hickman, B. Zacharia, B. Grobelny, P. Derosa et al., Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage, Neurological Research, vol.25, issue.2, pp.706-716, 2010.
DOI : 10.1161/01.STR.27.10.1783

C. Washington, D. Schuerer, and R. Grubb, Platelet Transfusion: An Unnecessary Risk for Mild Traumatic Brain Injury Patients on Antiplatelet Therapy, The Journal of Trauma: Injury, Infection, and Critical Care, vol.71, issue.2, pp.358-63, 2011.
DOI : 10.1097/TA.0b013e318220ad7e

R. Patal, T. Jonas-kimchi, N. Margalit, Z. Ram, O. Bental et al., The effect of platelet transfusion on traumatic intracranial hemorrhage among patients treated with aspirin]. Harefuah, pp.29-33, 2012.

R. Kaufman, B. Djulbegovic, T. Gernsheimer, S. Kleinman, A. Tinmouth et al., Platelet Transfusion: A Clinical Practice Guideline From the AABB, Annals of Internal Medicine, vol.162, issue.3, p.205
DOI : 10.7326/M14-1589

C. Samama, R. Djoudi, T. Lecompte, N. Nathan-denizot, J. Schved et al., Transfusion p??riop??ratoire de plaquettes: recommandations de l???Agence fran??aise de s??curit?? sanitaire des produits de sant?? (AFSSaPS) 2003, Canadian Journal of Anesthesia/Journal canadien d'anesth??sie, vol.13, issue.Suppl 2, pp.30-37, 2005.
DOI : 10.1007/BF03018577

L. Estcourt, J. Birchall, S. Allard, S. Bassey, P. Hersey et al., Guidelines for the use of platelet transfusions, British Journal of Haematology, vol.66, issue.Suppl. 1, pp.365-94, 2017.
DOI : 10.1016/s0140-6736(16)30392-0

D. Downey, B. Monson, K. Butler, G. Fortuna, J. Saxe et al., Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications? Am Surg, pp.1100-1103, 2009.

Y. Suzuki, T. Kitahara, K. Soma, S. Konno, K. Sato et al., Impact of Platelet Transfusion on Survival of Patients with Intracerebral Hemorrhage after Administration of Anti-Platelet Agents at a Tertiary Emergency Center, PLoS ONE, vol.73, issue.5, 2014.
DOI : 10.1371/journal.pone.0097328.t007

H. Schrezenmeier and E. Seifried, Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang, pp.1-15, 2010.
DOI : 10.1111/j.1423-0410.2009.01295.x

URL : https://repository.library.georgetown.edu/handle/10822/707940

S. Chen, Q. Yang, G. Chen, and J. Zhang, An update on inflammation in the acute phase of intracerebral hemorrhage. Transl Stroke Res, Feb, vol.6, issue.1, pp.4-8, 2015.

E. Mracsko and R. Veltkamp, Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci [Internet] Available from, 2014.
DOI : 10.3389/fncel.2014.00388

URL : http://doi.org/10.3389/fncel.2014.00388

Y. Fu, Q. Liu, J. Anrather, and F. Shi, Immune interventions in stroke, Nature Reviews Neurology, vol.8, issue.9, 2015.
DOI : 10.1038/nrneurol.2015.144

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851339

F. Cognasse, H. Hamzeh-cognasse, S. Lafarge, O. Delezay, B. Pozzetto et al., Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets, British Journal of Haematology, vol.306, issue.1, pp.84-91, 2008.
DOI : 10.1161/01.RES.0000160077.17427.57

Y. Wang, P. Wang, H. Fang, J. Chen, X. Xiong et al., Toll-Like Receptor 4 Antagonist Attenuates Intracerebral Hemorrhage-Induced Brain Injury, Stroke, vol.44, issue.9, pp.2545-52, 2013.
DOI : 10.1161/STROKEAHA.113.001038

H. Fang, J. Chen, S. Lin, P. Wang, Y. Wang et al., CD36-Mediated Hematoma Absorption following Intracerebral Hemorrhage: Negative Regulation by TLR4 Signaling, The Journal of Immunology, vol.192, issue.12, pp.5984-92, 1950.
DOI : 10.4049/jimmunol.1400054

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049082

J. Eikelboom, J. Hirsh, J. Weitz, M. Johnston, Q. Yi et al., Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events, Circulation, vol.105, issue.14, pp.1650-1655, 2002.
DOI : 10.1161/01.CIR.0000013777.21160.07

P. Gum, K. Kottke-marchant, P. Welsh, J. White, and E. Topol, A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease, Journal of the American College of Cardiology, vol.41, issue.6, pp.961-966, 2003.
DOI : 10.1016/S0735-1097(02)03014-0

S. Matetzky, B. Shenkman, V. Guetta, M. Shechter, R. Beinart et al., Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation, pp.3171-3176, 2004.

T. Geisler, H. Langer, M. Wydymus, K. Göhring, C. Zürn et al., Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation, European Heart Journal, vol.27, issue.20, pp.2420-2425, 2006.
DOI : 10.1093/eurheartj/ehl275

M. Hovens, J. Snoep, J. Eikenboom, J. Van-der-bom, B. Mertens et al., Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review, American Heart Journal, vol.153, issue.2, pp.175-81, 2007.
DOI : 10.1016/j.ahj.2006.10.040

A. Tanrikulu, B. Ozben, M. Koc, N. Papila-topal, T. Ozben et al., Aspirin resistance in patients with chronic renal failure, Journal of Nephrology, vol.24, issue.5, pp.636-682, 2011.
DOI : 10.5301/JN.2011.6259

C. Combescure, P. Fontana, N. Mallouk, P. Berdague, C. Labruyere et al., Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis, Journal of Thrombosis and Haemostasis, vol.8, issue.5, pp.923-956, 2010.
DOI : 10.1111/j.1538-7836.2010.03809.x

J. Mega, T. Simon, J. Collet, J. Anderson, E. Antman et al., Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI, JAMA, vol.304, issue.16, pp.1821-1851, 2010.
DOI : 10.1001/jama.2010.1543

D. Small, C. Payne, P. Kothare, E. Yuen, F. Natanegara et al., Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trial, Clinical Therapeutics, vol.32, issue.2, pp.365-79, 2010.
DOI : 10.1016/j.clinthera.2010.02.015

R. Teng and K. Butler, Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects, European Journal of Clinical Pharmacology, vol.10, issue.Suppl D, pp.487-96, 2010.
DOI : 10.1007/s00228-009-0778-5

M. Zafar, C. Santos-gallego, D. Vorchheimer, J. Viles-gonzalez, S. Elmariah et al., Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation, Journal of Thrombosis and Haemostasis, vol.271, issue.1, pp.100-106
DOI : 10.1111/jth.12058

G. Vilahur, B. Choi, M. Zafar, J. Viles-gonzalez, D. Vorchheimer et al., Normalization of platelet reactivity in clopidogrel-treated subjects, Journal of Thrombosis and Haemostasis, vol.44, issue.1, pp.82-90, 2007.
DOI : 10.1111/j.1538-7836.2006.02245.x

F. Prüller, C. Drexler, S. Archan, S. Macher, R. Raggam et al., Low platelet reactivity is recovered by transfusion of stored platelets: a healthy volunteer in vivo study, Journal of Thrombosis and Haemostasis, vol.120, issue.8, pp.1670-1673, 2011.
DOI : 10.1111/j.1538-7836.2011.04392.x